Adaptive Device for Insulin Pens for Arthritic Patients

Stopped early · Not applicable

Conditions studied: Diabetes Mellitus, Arthritis

In brief

Approximately 34 subjects will be enrolled in an unblinded cross-over design. For one week, they will use the adaptive pen device and for the next week, they will use just the insulin (or other medication) pen. This will be repeated for another one week period each. At the end of each week, the subjects will fill out a questionnaire regarding their experiences and any suggestions for improvements for the design of the pen device.

Key facts

Study ID

NCT02779816

Run by

Levenson, David I., M.D.

People needed

3

Starts

2017-05-01

Expected to finish

2018-07-02

Last updated by the study team

2019-08-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Currently using a pen to administer medication at least once a week
• Currently are having some difficulty (self reported) using their pens because of dexterity issues

You may not qualify if…

• Woman of child-bearing age who are known to be pregnant
• People who are unable or unwilling to sign the informed consent document
• Patients who do not understand the proper use of the device after sufficient instruction
• Anyone in the Principal Investigator's judgment who cannot properly use the device

Where it is running

• East Coast Medical Associates — Boca Raton, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.